Comments
Loading...

Lyell Immunopharma

LYELNASDAQ
Logo brought to you by Benzinga Data
$0.916600
-0.11-11.01%
At close: -
$0.919900
0.00330.36%
After Hours: 5:08 PM EDT

Lyell Immunopharma (NASDAQ:LYEL) Stock Quotes, Forecast and News Summary

Lyell Immunopharma Stock (NASDAQ: LYEL) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
1
Jun
1
Aug
1
1
Oct
1
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
1.5
Strong Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$1.01
Close$0.92
Volume / Avg.1.27M / 1.16M
Day Range$0.92 - $1.04
52 Wk Range0.85 - 3.26
Market Cap$256.86M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
42
Short Interest
5.47%
Days to Cover4.57

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
LYEL
VYGR

FAQ

Q

How do I buy Lyell Immunopharma (LYEL) stock?

A

You can purchase shares of Lyell Immunopharma (NASDAQ:LYEL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Lyell Immunopharma (LYEL) competitors?

Q

What is the forecast, or price target, for Lyell Immunopharma (LYEL) stock?

A

Lyell Immunopharma has a consensus price target of $2.75.

Q

What is the current price for Lyell Immunopharma (LYEL)?

A

The stock price for Lyell Immunopharma (NASDAQ: LYEL) is $0.9199 last updated November 21, 2024 at 5:08 PM EST.

Q

Does Lyell Immunopharma (LYEL) pay a dividend?

A

There are no upcoming dividends for Lyell Immunopharma.

Q

When is Lyell Immunopharma (NASDAQ:LYEL) reporting earnings?

A

Lyell Immunopharma’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Q

Is Lyell Immunopharma (LYEL) going to split?

A

There is no upcoming split for Lyell Immunopharma.

Q

What sector and industry does Lyell Immunopharma (LYEL) operate in?

A

Lyell Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch